A meta-analysis of the diabetic patient gene expression profiles has demonstrated that CCR2 may be a promising biomarker for diabetes mellitus and diabetic peripheral neuropathy [40], but more research is needed on this topic. Here, CCR2 is linked to diabetes mellitus.